杏吧原创

Celera Genomics, the Maryland-based company in the forefront of the race to
unravel the human genome, said last week that it had sequenced 95 per cent of
the mouse genome, from three strains. 鈥淭he mouse genome is an invaluable tool to
interpret the human genome,鈥� says Craig Venter, Celera鈥檚 president. A spokesman
for Britain鈥檚 Wellcome Trust says that its plan to spend 拢39 million with
the US National Institutes of Health sequencing the genome of a fourth mouse
strain does not put them in competition with Celera. 鈥淲e are sequencing a
different strain of mouse. The two approaches are complementary,鈥� she says.